Shanghai Rendu Biotechnology Co., Ltd. (688193.SS)
- Previous Close
37.00 - Open
37.19 - Bid 38.00 x --
- Ask 38.21 x --
- Day's Range
36.71 - 38.24 - 52 Week Range
23.00 - 50.30 - Volume
518,286 - Avg. Volume
355,995 - Market Cap (intraday)
1.52B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-0.26 - Earnings Date --
- Forward Dividend & Yield 0.30 (0.81%)
- Ex-Dividend Date Oct 30, 2024
- 1y Target Est
--
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.
www.rdbio.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 688193.SS
View MorePerformance Overview: 688193.SS
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688193.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688193.SS
View MoreValuation Measures
Market Cap
1.48B
Enterprise Value
712.38M
Trailing P/E
68.52
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.32
Price/Book (mrq)
1.62
Enterprise Value/Revenue
4.11
Enterprise Value/EBITDA
37.99
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.16%
Return on Assets (ttm)
-0.74%
Return on Equity (ttm)
-0.78%
Revenue (ttm)
177.35M
Net Income Avi to Common (ttm)
-7.38M
Diluted EPS (ttm)
-0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
677.85M
Total Debt/Equity (mrq)
0.52%
Levered Free Cash Flow (ttm)
-47.03k